Protocol Ledger

NCT03619551 · Phase II · ACTIVE NOT RECRUITING

Conditioning SCID Infants Diagnosed Early

Interventional Phase II clinical trial protocol NCT03619551 sponsored by Center for International Blood and Marrow Transplant Research in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-10-22 Enrollment: 56 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03619551
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)56 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03619551
Protocol FieldVerified Registry Value
NCT IdentifierNCT03619551
Consolidated Lead SponsorCenter for International Blood and Marrow Transplant Research
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment56 participants (ESTIMATED)
Registered Start Date2018-10-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI